WallStreetZenWallStreetZen

NASDAQ: TTRX
Turn Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TTRX

Based on 1 analyst offering 12 month price targets for Turn Therapeutics Inc

Min Forecast
$8.00+133.24%
Avg Forecast
$8.00+133.24%
Max Forecast
$8.00+133.24%

Should I buy or sell TTRX stock?

Based on 1 analyst offering ratings for Turn Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TTRX stock forecasts and price targets.

TTRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-24

1 of 1

Forecast return on equity

Is TTRX forecast to generate an efficient return?

Company
-110.21%
Industry
31.71%
Market
160.36%
TTRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TTRX forecast to generate an efficient return on assets?

Company
-42.47%
Industry
4.65%
TTRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TTRX earnings per share forecast

What is TTRX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.11
Avg 2 year Forecast
-$0.26
Avg 3 year Forecast
-$0.17

TTRX revenue forecast

What is TTRX's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$204.0M
Avg 2 year Forecast
$2.6M
Avg 3 year Forecast
$0.0

TTRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TTRX$3.43$8.00+133.24%Strong Buy
VRCA$5.91$17.00+187.65%Strong Buy
CBUS$1.44$9.00+525.00%Buy
GOSS$0.45$2.06+356.76%Hold
ANIX$2.93$10.00+241.30%Strong Buy
View Top Biotech Stocks

Turn Therapeutics Stock Forecast FAQ

Is Turn Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TTRX) stock is to Strong Buy TTRX stock.

Out of 1 analyst, 1 (100%) are recommending TTRX as a Strong Buy, 0 (0%) are recommending TTRX as a Buy, 0 (0%) are recommending TTRX as a Hold, 0 (0%) are recommending TTRX as a Sell, and 0 (0%) are recommending TTRX as a Strong Sell.

If you're new to stock investing, here's how to buy Turn Therapeutics stock.

What is TTRX's earnings growth forecast for 2026-2028?

(NASDAQ: TTRX) Turn Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 73.59%.

Turn Therapeutics's earnings in 2026 is -$3,194,080.On average, 4 Wall Street analysts forecast TTRX's earnings for 2026 to be -$3,342,218, with the lowest TTRX earnings forecast at -$3,503,074, and the highest TTRX earnings forecast at -$3,127,744. On average, 4 Wall Street analysts forecast TTRX's earnings for 2027 to be -$7,747,869, with the lowest TTRX earnings forecast at -$10,509,221, and the highest TTRX earnings forecast at -$4,691,616.

In 2028, TTRX is forecast to generate -$5,165,246 in earnings, with the lowest earnings forecast at -$4,962,687 and the highest earnings forecast at -$5,317,165.

What is TTRX's revenue growth forecast for 2026-2028?

(NASDAQ: TTRX) Turn Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 53.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 17.32%.

Turn Therapeutics's revenue in 2026 is $0.On average, 4 Wall Street analysts forecast TTRX's revenue for 2026 to be $6,076,760,160, with the lowest TTRX revenue forecast at $0, and the highest TTRX revenue forecast at $12,510,976,800. On average, 4 Wall Street analysts forecast TTRX's revenue for 2027 to be $77,478,692, with the lowest TTRX revenue forecast at $0, and the highest TTRX revenue forecast at $159,514,954.

In 2028, TTRX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is TTRX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: TTRX) forecast ROA is -42.47%, which is lower than the forecast US Biotechnology industry average of 4.65%.

What is TTRX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TTRX price target, the average TTRX price target is $8.00, with the highest TTRX stock price forecast at $8.00 and the lowest TTRX stock price forecast at $8.00.

The Wall Street analyst predicted that Turn Therapeutics's share price could reach $8.00 by Mar 24, 2027. The average Turn Therapeutics stock price prediction forecasts a potential upside of 133.24% from the current TTRX share price of $3.43.

What is TTRX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TTRX) Turn Therapeutics's current Earnings Per Share (EPS) is -$0.12. On average, analysts forecast that TTRX's EPS will be -$0.11 for 2026, with the lowest EPS forecast at -$0.12, and the highest EPS forecast at -$0.11. On average, analysts forecast that TTRX's EPS will be -$0.26 for 2027, with the lowest EPS forecast at -$0.35, and the highest EPS forecast at -$0.16. In 2028, TTRX's EPS is forecast to hit -$0.17 (min: -$0.17, max: -$0.18).

What is TTRX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: TTRX) forecast ROE is -110.21%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.